Title  | Date  | Price |
|---|
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA
| Aug 2007 |
£9,140 |
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products
| Aug 2007 |
£9,140 |
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics
| Aug 2007 |
£6,855 |
R&D Strategies
Incremental improvements & paradigm shifts in strategy are both necessary to boost productivity
| Aug 2007 |
£9,140 |
RNA Interference for Drug R&D
Applications, Alliances, Companies and WW Market to 2011
| Jul 2007 |
£1,560 |
Industry Insight Clinical Trials in India 2007
| May 2007 |
£400 |
Outsourcing Clinical Trials
A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
| May 2007 |
£1,805 |
The Emerging Markets of Clinical Research
| May 2007 |
£155 |
State of the Clinical Trials Industry 2007
| May 2007 |
£370 |
Innovations and Trends in Clinical Trials
Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
| Mar 2007 |
£1,355 |
Indication Expansion
Opportunities for successful lifecycle management
| Mar 2007 |
£1,150 |
Translational Medicine
Drug Development Transformed? (Market Focus)
| Feb 2007 |
£1,140 |
Comprehensive Analysis of R&D and Commercialization
for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100
| Feb 2007 |
£990 |
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
| Feb 2007 |
£1,150 |
CRO Directory
India
| Jan 2007 |
£400 |
How Drugs Are Developed
3rd Edition
| Jan 2007 |
£1,095 |
Reinventing Patient Recruitment
Revolutionary Ideas for Clinical Trial Success
| Jan 2007 |
£95 |
Mastering Phase IV Clinical Trials
| Jan 2007 |
£2,720 |
Automated Biobanking Trends 2006
| Dec 2006 |
£1,540 |
Successfully Marketing Clinical Trial Results
Winning in the Healthcare Business
| Dec 2006 |
£95 |
GPCR Screening & Profiling Trends 2006
| Nov 2006 |
£1,540 |
Independent Clinical Laboratores
| Oct 2006 |
£310 |
Reporting Adverse Events
| Sep 2006 |
£75 |
Accelerating Patient Recruitment in Clinical Trials
| Jul 2006 |
£75 |
New Drug Futures: Alimentary/Metabolic Chapter
| May 2006 |
£695 |
New Drug Futures: Anti-Infective Chapter
| May 2006 |
£695 |
New Drug Futures: Cardiovascular Chapter
| May 2006 |
£695 |
New Drug Futures: Vaccines Chapter
| May 2006 |
£695 |
New Drug Futures: Musculoskeletal Chapter
| May 2006 |
£695 |
New Drug Futures: Cancer Chapter
| May 2006 |
£695 |
New Drug Futures: Central Nervous System Chapter
| May 2006 |
£695 |
New Drug Futures: Respiratory Chapter
| May 2006 |
£695 |
The Impact of the Phase III Pipeline
Future Projections and Market Disruptions
| Mar 2006 |
£2,105 |
Clinical Trials Business; The
| Jan 2006 |
£2,915 |
Scrip R&D Databook 2006
| Jan 2006 |
£1,295 |
Clinical Trials in India
Industry Report
| Nov 2005 |
£400 |
Strategies for Innovation in Pharmaceutical R&D
Enhancing R&D Through Biotech Alliances and CRO Outsourcing
| Mar 2005 |
£450 |
Biosensor Market, R&D and Commercial Implication
| Apr 2004 |
£660 |
Research & Development in the Pharmaceutical Industry
Options for success
| Feb 2004 |
£825 |
From Breakthrough to Blockbuster
Best Practices in Communicating Clinical Trial Results
| May 2003 |
£3,225 |
Life Science Tools and Technologies for Bio-Pharma R&D
Instruments, Tech Platforms, Informatics and Market
| Mar 2003 |
£900 |
first
previous
